The High Density (HD) Cell Banking Market is estimated to secure an aggressive CAGR of 8.4% during the forecast period. The market projected the valuation at USD 13.12 Billion in 2022 and is likely to be valued at USD 29.39 Billion by 2032.
| Attributes | Details |
|---|---|
| Market CAGR (2022 to 2032) | 8.4% |
| Market Value (2022) | USD 13.12 Billion |
| Market Value (2032) | USD 29.39 Billion |
The rising demand for high density (HD) cell banking is due to it being widely used in drug development, biological research and medical use. The high density (HD) cell banking is a process of storing cells belonging to a specific genome that eliminates delay. The market is expected to grow at a moderate pace by occupying a significant size during the forecast period.
The demand for high density (HD) cell banking is rising to do research work in the biotechnology and medical sector. On the flip side, increasing biological drug applications, cell culture techniques and the growing life science sector are driving the market expansion.
The growing demand for therapeutic areas due to research related to cancer disease drives the market share. In addition, high retention increases the productivity of high density cell banking which observes healthy high density (HD) cell banking market growth.
The adoption of high density (HD) cell banking process to extract cells, store them, and use them for clinical research is anticipated to increase the market size during the forecast period. The demand for high density (HD) cell banking techniques is reducing the chance of contamination.
The high density (HD) cell banking reduces the time process, adds several expansion steps, and increases the automation process, which is likely to drive the market size. Moreover, the growing advanced technologies and increased adoption of high density cell banking for clinical and laboratory purposes are driving the market expansion.
The end-user industries such as pharmaceutical companies, research centers, academic institutions and biotechnology companies are growing their market share.
North America dominates the global high density (HD) cell banking market by occupying a significant share. The rising adoption of high density cell banking and healthcare infrastructure is increasing the market size. In addition, the rapidly growing pharmaceutical sector and the biotechnology and RD institutes are accelerating market growth.
Cell banking is a process of separation and storage of cells belonging to a specific genome which are used in biological research, drug development, and medical use. The cell banking technique involves a lengthy process of extraction, and scale - up owing to which the cells become more susceptible to contamination and lot of time is wasted before the cells are actually used for research or clinical purpose.
High density (HD) cell banking technique is used to eliminate delay and reducing the chance of contamination.. The HD cell banking technique reduces the number of expansion steps involved in the scaling - up process which are required in the traditional cell culture and turn reduces the process time and increases the level of automation in the process.
In high-density cell culture technique, the cells are dispensed directly into single-use bioreactor or culture vessel which in turn speeds up the creation of homogenous cells and eliminates the need for centrifugation and dilution processes, moreover high-density cell culture reduces the interactions with the culture and in turn reduces the risk of contamination.
High-density cell cultures market is expected witness robust growth over the forecast period owing to its technological advantages over traditional cell culture techniques.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for High Density (HD) Cell Banking is fueled by growing research and development spending in biotechnology and medical industry. The growing life science industry and increasing applications of biological drugs derived through genetic engineering and cell culture techniques.
High retention of the cells in the high-density cell culture, increases productivity owing to which HD cell banking market is expected to witness robust growth over the forecast period. Growing demand for stem cell research in therapeutic areas like cancer and autoimmune diseases worldwide is expected to boost demand for high-density cell banking over the forecast period.
Moreover the adoption of cell culture processes for manufacturing of industrial enzymes and other proteins is growing especially in the developed and emerging economies which in turn is expected to boost demand for high density cell banking globally, however low awareness of the technology and lack of technical expertise is expected to hamper revenue growth of the high-density cell banking market over the forecast period.
The high density (HD), cell banking market, is largely penetrated by some key global players and is expected to witness healthy CAGR regarding revenue owing to increasing applications and high adoption rate of high density (HD) cell banking technique in research and academics globally. The entry of new players and development of enhanced technology in the high density (HD) cell banking market is expected to create fierce competition over the forecast period in the market.
Principal Consultant
Geographically, the global high density (HD), cell banking market, is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, Middle East and Africa (MEA).
North America dominates the global high density (HD) cell banking market followed by Europe. North America and Western Europe (comprising EU5 countries) regions are expected to witness significant growth due to increased adoption of high density (HD) cell banking and due to awareness in these regions.
APEJ is expected to witness significant growth as compared to other regions and countries owing to increase in spending in pharmaceutical sector and presence of several biotechnology and research and development institutions. Latin America and MEA regions are expected to witness sluggish growth due to low adoption of high density (HD) cell banking equipment. However, increasing healthcare spending may boost the growth of high density (HD) cell banking market in these regions during the forecast period.
Some of the major players operating in the market for High Density (HD) Cell Banking are Genzyme Corporation, REPLIGEN CORPORATION, Pall Corporation, General Electric Company, Sartorius AG, Merck Millipore Thermo Fisher Scientific Inc. and others. Above manufactures are upgrading the traditional technology and concentrating on market penetration.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global high density (HD), cell banking market, is classified on the basis of end user and regional presence.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. End Users 7. Global Market Analysis and Forecast, By End Users 7.1. Pharmaceuticals Companies 7.2. Biotechnology Companies 7.3. Chemical & Material 7.4. Agriculture 7.5. Academic & Research Institutes 8. Global Market Analysis and Forecast, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. Asia Pacific Excluding Japan 8.6. Japan 8.7. Middle East & Africa 9. North America Sales Analysis and Forecast, by Key Segments and Countries 10. Latin America Sales Analysis and Forecast, by Key Segments and Countries 11. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 12. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Asia Pacific Excluding Japan Sales Analysis and Forecast, by Key Segments and Countries 14. Japan Sales Analysis and Forecast, by Key Segments and Countries 15. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries 16. Sales Forecast by End Users for 30 Countries 17. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 18. Company Profile 18.1. Genzyme Corporation 18.2. REPLIGEN CORPORATION 18.3. Pall Corporation 18.4. General Electric Company 18.5. Sartorius AG 18.6. Merck Millipore 18.7. Thermo Fisher Scientific Inc.
Explore Healthcare Insights
View Reports
High Density (HD) Cell Banking Market
